Three versus six months adjuvant FOLFOX or CAPOX for high risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant chemotherapy (IDEA) project.
暂无分享，去创建一个
V. Georgoulias | I. Boukovinas | N. Ziras | C. Emmanouilides | D. Mavroudis | J. Souglakos | G. Papadopoulos | S. Kakolyris | A. Ardavanis | A. Athanasiadis | A. Christopoulou | N. Kentepozidis | P. Makrantonakis | M. Vaslamatzis | N. Androulakis | S. Kakolyris | A. Karampeazis | G. Papadopoulos | E. Athanasiadis | M. Vaslamatzis | N. Androulakis | C. Kourousis | S. Xynogalos | I. Bompolaki | C. Christofyllakis | U. Katopodi | A. Anagnosopoulos | E. Prinarakis | A. Kalisperi | V. Georgoulias | N. Ziras | U. Katopodi | A. Anagnosopoulos | A. Kalisperi